Go Pro
→ Trump Takes Emergency Action - Plus Elon Musk's New Venture (From Altimetry) (Ad)tc pixel

MarketBeat Instant News Alerts

Carlyle Group logo with Finance background

Carlyle Group Q2 Earnings Call Highlights

MarketBeat

Carlyle Group (NASDAQ:CG) reported second-quarter results marked by record fee-related earnings, strong fundraising and higher realized performance revenue, as the alternative asset manager said it was entering a period in which nearly all of its core strategies will be seeking capital. Distributab

NASDAQ:CG
Read Carlyle Group Q2 Earnings Call Highlights
CDW logo with Technology background

CDW Q2 Earnings Call Highlights

MarketBeat

CDW (NASDAQ:CDW) reported record second-quarter results for 2026, as demand for infrastructure modernization, artificial intelligence readiness and security helped lift net sales 10% to $6.6 billion. The technology solutions provider said gross profit increased 6% to $1.3 billion, while non-GAAP op

NASDAQ:CDW
Read CDW Q2 Earnings Call Highlights
Bioventus logo with Healthcare background

Bioventus Q2 Earnings Call Highlights

MarketBeat

Bioventus (NASDAQ:BVS) reported second-quarter 2026 revenue growth of 4% and reiterated its full-year financial outlook, citing double-digit expansion in its Pain Treatments business, continued debt reduction and increased investment in platelet-rich plasma, peripheral nerve stimulation, Ultrasonics

NASDAQ:BVS
Read Bioventus Q2 Earnings Call Highlights
BioCryst Pharmaceuticals logo with Healthcare background

BioCryst Pharmaceuticals Q2 Earnings Call Highlights

MarketBeat

BioCryst Pharmaceuticals (NASDAQ:BCRX) reported second-quarter results marked by growth in ORLADEYO revenue, the start of shipments for its pediatric oral-pellet formulation, and completion of enrollment in its pivotal navenibart trial for hereditary angioedema, or HAE. President and CEO Charlie Ga

NASDAQ:BCRX
Read BioCryst Pharmaceuticals Q2 Earnings Call Highlights
Azenta logo with Healthcare background

Azenta Q3 Earnings Call Highlights

MarketBeat

Azenta (NASDAQ:AZTA) reported third-quarter fiscal 2026 revenue that exceeded its outlook, as growth in recurring-revenue businesses and improved Multiomics performance helped offset continued unevenness in capital equipment markets. Total revenue was $161 million, up 12% on a reported basis and 9%

NASDAQ:AZTA
Read Azenta Q3 Earnings Call Highlights
Astec Industries logo with Industrials background

Astec Industries Q2 Earnings Call Highlights

MarketBeat

Astec Industries (NASDAQ:ASTE) reported record second-quarter revenue and adjusted EBITDA, supported by growth in its Materials Solutions business, higher parts and service sales, and contributions from concrete, mobile paving and forestry equipment. The company also reduced its full-year adjusted E

NASDAQ:ASTE
Read Astec Industries Q2 Earnings Call Highlights

Trending News

1Tilray Brands (NASDAQ:TLRY) Rating Increased to Strong-Buy at TD Securities
2BlackBerry Limited $BB Shares Purchased by Renaissance Technologies LLC
3Archer Aviation (ACHR) Projected to Announce Quarterly Earnings on Monday
4Rocket Lab (RKLB) to Post Quarterly Earnings on Monday
5Northland Securities Predicts BigBear.ai Q1 Earnings
6Plug Power (PLUG) Expected to Release Quarterly Earnings on Monday
7Alphabet (NASDAQ:GOOG) Stock Price Up 6.9% - Should You Buy?
8Advanced Micro Devices Q2 Earnings Call Highlights

All MarketBeat Instant News Alerts

Angi logo with Communication Services background

Angi Q2 Earnings Call Highlights

MarketBeat
NASDAQ:ANGI
Read Angi Q2 Earnings Call Highlights
Advantage Solutions logo with Communication Services background

Advantage Solutions Q2 Earnings Call Highlights

MarketBeat
NASDAQ:ADV
Read Advantage Solutions Q2 Earnings Call Highlights
Zotefoams logo with Materials background

Zotefoams H1 Earnings Call Highlights

MarketBeat
LON:ZTF
Read Zotefoams H1 Earnings Call Highlights
Vonovia logo with Real Estate background

Vonovia Q2 Earnings Call Highlights

MarketBeat
ETR:VNA
Read Vonovia Q2 Earnings Call Highlights
Insulet logo with Healthcare background

Insulet (NASDAQ:PODD) Hits New 12-Month Low - Here's Why

MarketBeat
NASDAQ:PODD
Read Insulet (NASDAQ:PODD) Hits New 12-Month Low - Here's Why
Navan logo with Technology background

Navan (NASDAQ:NAVN) Hits New 12-Month High - Still a Buy?

MarketBeat
NASDAQ:NAVN
Read Navan (NASDAQ:NAVN) Hits New 12-Month High - Still a Buy?
Etsy logo with Consumer Discretionary background

Etsy (NYSE:ETSY) Hits New 12-Month High - Should You Buy?

MarketBeat
NYSE:ETSY
Read Etsy (NYSE:ETSY) Hits New 12-Month High - Should You Buy?
Oruka Therapeutics logo with Healthcare background

Oruka Therapeutics (NASDAQ:ORKA) Hits New 12-Month High - What's Next?

MarketBeat
NASDAQ:ORKA
Read Oruka Therapeutics (NASDAQ:ORKA) Hits New 12-Month High - What's Next?
Travere Therapeutics logo with Healthcare background

Travere Therapeutics (NASDAQ:TVTX) Sets New 52-Week High - Here's Why

MarketBeat
NASDAQ:TVTX
Read Travere Therapeutics (NASDAQ:TVTX) Sets New 52-Week High - Here's Why
Palo Alto Networks logo with Technology background

Palo Alto Networks (NASDAQ:PANW) Reaches New 12-Month High - Still a Buy?

MarketBeat
NASDAQ:PANW
Read Palo Alto Networks (NASDAQ:PANW) Reaches New 12-Month High - Still a Buy?
Crown logo with Materials background

Crown (NYSE:CCK) Sets New 52-Week High - What's Next?

MarketBeat
NYSE:CCK
Read Crown (NYSE:CCK) Sets New 52-Week High - What's Next?
First Community Bancshares logo with Finance background

First Community Bancshares (NASDAQ:FCBC) Sets New 52-Week High - Still a Buy?

MarketBeat
NASDAQ:FCBC
Read First Community Bancshares (NASDAQ:FCBC) Sets New 52-Week High - Still a Buy?
MSC Industrial Direct logo with Industrials background

MSC Industrial Direct (NYSE:MSM) Sets New 1-Year High - What's Next?

MarketBeat
NYSE:MSM
Read MSC Industrial Direct (NYSE:MSM) Sets New 1-Year High - What's Next?
Fortinet logo with Technology background

Fortinet (NASDAQ:FTNT) Sets New 12-Month High - Here's What Happened

MarketBeat
NASDAQ:FTNT
Read Fortinet (NASDAQ:FTNT) Sets New 12-Month High - Here's What Happened
Geo Group logo with Industrials background

Geo Group (NYSE:GEO) Reaches New 12-Month High - Should You Buy?

MarketBeat
NYSE:GEO
Read Geo Group (NYSE:GEO) Reaches New 12-Month High - Should You Buy?
Pinterest logo with Communication Services background

Wedbush Reaffirms "Neutral" Rating for Pinterest (NYSE:PINS)

MarketBeat
NYSE:PINS
Read Wedbush Reaffirms "Neutral" Rating for Pinterest (NYSE:PINS)
United Parks & Resorts logo with Consumer Discretionary background

United Parks & Resorts (NYSE:PRKS) Price Target Raised to $54.00

MarketBeat
NYSE:PRKS
Read United Parks & Resorts (NYSE:PRKS) Price Target Raised to $54.00
TKO Group logo with Communication Services background

TKO Group (NYSE:TKO) Stock Price Expected to Rise, Guggenheim Analyst Says

MarketBeat
NYSE:TKO
Read TKO Group (NYSE:TKO) Stock Price Expected to Rise, Guggenheim Analyst Says
Viking logo with Consumer Discretionary background

Wells Fargo & Company Issues Positive Forecast for Viking (NYSE:VIK) Stock Price

MarketBeat
NYSE:VIK
Read Wells Fargo & Company Issues Positive Forecast for Viking (NYSE:VIK) Stock Price
Wayfair logo with Consumer Discretionary background

Wayfair (NYSE:W) Given New $125.00 Price Target at Wedbush

MarketBeat
NYSE:W
Read Wayfair (NYSE:W) Given New $125.00 Price Target at Wedbush
Advanced Micro Devices logo with Technology background

Advanced Micro Devices (NASDAQ:AMD) Earns "Outperform" Rating from Wedbush

MarketBeat
NASDAQ:AMD
Read Advanced Micro Devices (NASDAQ:AMD) Earns "Outperform" Rating from Wedbush
Booking logo with Consumer Discretionary background

Wedbush Increases Booking (NASDAQ:BKNG) Price Target to $247.00

MarketBeat
NASDAQ:BKNG
Read Wedbush Increases Booking (NASDAQ:BKNG) Price Target to $247.00
Red Rock Resorts logo with Consumer Discretionary background

Wells Fargo & Company Issues Positive Forecast for Red Rock Resorts (NASDAQ:RRR) Stock Price

MarketBeat
NASDAQ:RRR
Read Wells Fargo & Company Issues Positive Forecast for Red Rock Resorts (NASDAQ:RRR) Stock Price
Spyre Therapeutics logo with Healthcare background

Spyre Therapeutics (NASDAQ:SYRE) Price Target Raised to $130.00 at Wedbush

MarketBeat
NASDAQ:SYRE
Read Spyre Therapeutics (NASDAQ:SYRE) Price Target Raised to $130.00 at Wedbush

Featured Articles and Offers

Why SK hynix Could Be the Best AI Chip Stock to Buy Now
Why SK hynix Could Be the Best AI Chip Stock to Buy Now
By Thomas Hughes | July 29, 2026
tc pixel
The end may be near for these iconic stocks
The end may be near for these iconic stocks
From Chaikin Analytics (Ad)
SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
By Jeffrey Neal Johnson | August 3, 2026
3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Story
3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Story
By Nathan Reiff | August 2, 2026
System Upgrade: First Internet Bancorp Options Surge
System Upgrade: First Internet Bancorp Options Surge
By Jeffrey Neal Johnson | August 4, 2026
tc pixel
A letter from Shannon Stansberry
A letter from Shannon Stansberry
From Porter & Company (Ad)
Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Why Bloom Energy May Be the Most Important AI Infrastructure Stock
By Thomas Hughes | July 29, 2026
Tilray Brands (NASDAQ:TLRY) Rating Increased to Strong-Buy at TD Securities
Tilray Brands (NASDAQ:TLRY) Rating Increased to Strong-Buy at TD Securities
By MarketBeat | August 1, 2026

Alert Categories

All Alerts
Page 1 of 508